Botox Resistance and Treatment Strategies
Introduction to Botox Resistance
- Distinguish true immunologic resistance from inadequate dosing, incorrect injection technique or muscle targeting, disease progression, with inadequate dosing and incorrect injection technique being key considerations 1, 2
Condition-Specific Treatment Strategies
- For cervical dystonia, abobotulinumtoxinA and rimabotulinumtoxinB are similarly effective and should be offered, as per the American Academy of Family Physicians 3
- For blepharospasm, onabotulinumtoxinA and incobotulinumtoxinA are equally effective and should be considered, as per the American Academy of Family Physicians 3
- For spasticity, abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA are all safe and effective for upper extremity spasticity, as per the American Academy of Family Physicians 3, 4
- For neurogenic lower urinary tract dysfunction, onabotulinumtoxinA (200-300 U) strongly improves bladder storage parameters, with no difference in efficacy between 200 U and 300 U doses, as reported in The Journal of Urology 1
Minimizing Future Resistance Risk
- Adjusting dose, distribution, and timing of injections can minimize adverse events, as per Praxis Medical Insights 2